A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)

Clinical trial NCT00681538 · COMPLETED

Trial details

NCT number: NCT00681538
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Spasticity Multiple Sclerosis

Start date: 2008-01-01
Primary completion: 2009-01-01
Enrollment: 572

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.